The commercially available Calbiochem β-secretase inhibitor has 15 times greater ability to inhibit BACE1 compared to BACE2 (according to the manufacturer) and it required prolonged time in culture to inhibit pancreatic cancer cell survival (Fig. 3D). The gene discussed is BACE2; the disease is familial pancreatic carcinoma.